Table 4.

Effect of PHCSBD on haematological parameters

Treatment	Dose (mg/kg)	Parasitaemia count
		RBC (106/μL)	WBC (103/μL)	PCV (%)	HB (g/dl)
Control	–	5.16 ± 3.88	8.22 ± 1..76	19.50 ± 1.59	5.75 ± 0.96
BePINH	2.5	9.81 ± 1.96	9.77 ± 1.37	38.25 ± 0.83*	10.63 ± 0.19*
	10	10.63 ± 1.28*	10.57 ± 2.02	36.50 ± 1.10*	11.03 ± 0.39*
	15	10.86 ± 1.11*	10.92 ± 1.70	37.25 ± 0.96*	12.18 ± 0.19*
BePBeH	2.5	8.24 ± 2.92	9.55 ± 1.56	36.87 ± 1.21*	10.71 ± 0.74*
	10	9.89 ± 1.31	10.41 ± 1.24	37.02 ± 0.92*	10.87 ± 0.81*
	15	10.31 ± 0.29*	10.85 ± 0.82	37.53 ± 1.01*	11.17 ± 1.25*
ACT	5	10.99 ± 1.17*	10.60 ± 1.70	41.50 ± 1.70*	12.00 ± 0.32*

Each value represents the mean ± S.E.M, n = 5

ACT Artemisinin-based Combination Therapy, RBC red blood cells, WBC white blood cells, PCV packed cell volume, HB haemoglobin

^*p < 0.05 compared with control (One-way ANOVA; Dunnett’s post hoc)